Quantcast

Latest Head and neck cancer Stories

2013-06-18 10:32:00

Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils. In their study, at least 1 in 3 individuals with oropharyngeal cancer had antibodies to HPV, compared to fewer than 1 in 100 individuals without cancer.  When present, these antibodies were detectable many years before the onset of disease. These...

2013-06-02 23:15:07

Mount Sinai researchers to present landmark studies at American Society of Clinical Oncology meeting. New York, NY (PRWEB) June 01, 2013 Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology (ASCO) meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus (HPV) oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer...

2013-05-02 23:15:21

Invado Pharmaceuticals announced that Cleveland Clinic Cancer Clinic presented positive clinical data on NeutraSal at ONS World Congress Meeting in Washington DC. The data suggested that NeutraSal is more effective than salt and soda rinses in reducing oral toxicities in head and neck cancer patients. Pomona, NY (PRWEB) May 02, 2013 Invado Pharmaceuticals announced that Jean Hamker, RN of the Cleveland Clinic Taussig Cancer Institute presented data from a NeutraSal study at last week's ONS...

2013-04-01 23:02:18

Oral Cancer Screenings for the public, April 17, 2013 4:00pm-until all patients are seen. Beaumont, TX (PRWEB) April 01, 2013 Gulfside Dental is providing free visual head and neck oral cancer exams on April 17th to educate Southeast Texas on the importance of early screening and detection in oral cancers. While all Gulfside Dental patients receive visual oral cancer screenings during regular visits, April is recognized as Oral Cancer Awareness Month by the Oral Cancer Foundation and...

2013-03-31 23:02:55

polyDNA will be lowering the price of Gene-Eden-VIR by 50% for those suffering from oral cancer during Oral Cancer Awareness Month. Rochester, NY (PRWEB) March 31, 2013 polyDNA is a leading developer of natural HPV remedies. As the Washington Times noted, ““¦(HPV) is the second leading cause of oral cancer.”[1] During the month of April, which has been sponsored by the Oral Cancer Foundation as Oral Cancer Awareness Month, polyDNA will be lowering the price of...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related